Chlortalidone and Bumetanide in Advanced Chronic Kidney Disease: HEBE-CKD Trial
Clinical trial NCT03923933 · COMPLETED
Trial details
- NCT number
- NCT03923933
- Sponsor
- Hospital General de México Dr. Eduardo Liceaga
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-18
- Primary completion
- 2019-10-28
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.